Search

Your search keyword '"Kanaan, Richard A."' showing total 521 results
Start Over Author "Kanaan, Richard A."
521 results on '"Kanaan, Richard A."'

6. Response to the Letter Concerning the Publication: Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda. Perez DL et al. Neuroimage Clin. 2021;30:102623

Author

Perez, David L., Nicholson, Timothy R., Asadi-Pooya, Ali A., Butler, Matthew, Carson, Alan J., David, Anthony S., Deeley, Quinton, Diez, Ibai, Edwards, Mark J., Espay, Alberto J., Gelauff, Jeannette M., Jungilligens, Johannes, Hallett, Mark, Kanaan, Richard A.A., Tijssen, Marina A.J., Kozlowska, Kasia, LaFrance, W. Curt, Jr, Marapin, Ramesh S., Maurer, Carine W., Reinders, Antje A.T.S., Sojka, Petr, Staab, Jeffrey P., Stone, Jon, Szaflarski, Jerzy P., and Aybek, Selma

Published
2024
Full Text
View/download PDF

8. Neuropsychological function in psychosis of epilepsy

Author

Allebone, James, Kanaan, Richard A., Rayner, Genevieve, Maller, Jerome, O’Brien, Terence J., Mullen, Saul A., Cook, Mark, Adams, Sophia J., Vogrin, Simon, Vaughan, David N., Kwan, Patrick, Berkovic, Samuel F., D’Souza, Wendyl J., Jackson, Graeme, Velakoulis, Dennis, and Wilson, Sarah J.

Published
2023
Full Text
View/download PDF

17. Making meaning: The experience of Shared Individual Formulation Therapy in adults with functional neurological disorder.

Author

Gutkin, Myles, Kanaan, Richard A., McLean, Loyola, Cartoon, Jodi, and Brown, Richard J.

Subjects
*SOMATOFORM disorders, *PSYCHOTHERAPY, *PSYCHODYNAMIC psychotherapy, *QUALITATIVE research, *RESEARCH funding, *INTERVIEWING, *PILOT projects, *CRISIS intervention (Mental health services), *DESCRIPTIVE statistics, *THEMATIC analysis, *RESEARCH methodology, *PATIENT satisfaction, *PATIENT participation, *SELF-perception, *ADULTS
Abstract

Objective: Shared Individual Formulation Therapy (SIFT) is a brief, hybrid psychotherapy intervention that uses shared formulation and psychodynamic psychotherapy techniques to help participants expand their understanding of their difficulties. It was used in a pilot study for 29 adults with functional neurological disorder (FND). This analysis explores the experiences of participants using qualitative methods. Method: Participants underwent semistructured interviews about their experiences of SIFT, which were analysed using reflexive thematic analysis from a critical realist standpoint. Findings were triangulated with the previously published quantitative results. Results: Participants experienced SIFT as providing a safe space to help them explore and make sense of their FND. The resulting self‐knowledge was experienced as promoting recovery and growth, but some participants experienced the process as challenging and were ambivalent about it. Conclusion: The findings support SIFT's potential value for treating adults with FND. The psychodynamic aspects are an important component of SIFT for many, but not all, participants. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. Enlarged hippocampal fissure in psychosis of epilepsy

Author

Allebone, James, Kanaan, Richard A., Maller, Jerome J., O'Brien, Terrence, Mullen, Saul, Cook, Mark, Adams, Sophie, Vogrin, Simon, Vaughan, David, Connelly, Alan, Kwan, Patrick, Berkovic, Samuel F., D'Souza, Wendyl, Jackson, Graeme, Velakoulis, Dennis, and Wilson, Sarah J.

Published
2020
Full Text
View/download PDF

34. Principles for delivering improved care of people with functional seizures: Closing the treatment gap.

Author

Winton-Brown, Toby, Wilson, Sarah J, Felmingham, Kim, Rayner, Genevieve, O'Brien, Terence J, O'Brien, Patrick, Mohan, Adith, Velakoulis, Dennis, and Kanaan, Richard

Subjects
OCCUPATIONAL roles, HOSPITAL shared services, HEALTH services accessibility, PROFESSIONS, MEDICAL triage, MEDICAL care, MEDICAL care costs, UNCERTAINTY, SOCIAL stigma, FAMILY attitudes, QUALITY assurance, CLINICAL competence, HEALTH care teams, SEIZURES (Medicine), PSYCHOLOGY of the sick, PHYSICIANS, THEMATIC analysis, DISEASE complications
Abstract

Patients diagnosed with functional (psychogenic nonepileptic) seizures have similar or greater levels of disability, morbidity and mortality than people with epilepsy, but there are far fewer treatment services. In contrast to epilepsy, the current understanding of pathophysiological mechanisms and the development of evidence-based treatments for functional seizures is rudimentary. This leads to high direct healthcare costs and high indirect costs to the patient, family and wider society. There are many patient, clinician and system-level barriers to improving outcomes for functional seizures. At a patient level, these include the heterogeneity of symptoms, diagnostic uncertainty, family factors and difficulty in perceiving psychological aspects of illness and potential benefits of treatment. Clinician-level barriers include sub-specialism, poor knowledge, skills and attitudes and stigma. System-level barriers include the siloed nature of healthcare, the high prevalence of functional seizures and funding models relying on individual medical practitioners. Through the examination of international examples and expert recommendations, several themes emerge that may address some of these barriers. These include (1) stepped care with low-level, brief generalised interventions, proceeding to higher level, extended and individualised treatments; (2) active triage of complexity, acuity and treatment readiness; (3) integrated interdisciplinary teams that individualise formulation, triage, and treatment planning and (4) shared care with primary, emergency and community providers and secondary consultation. Consideration of the application of these principles to the Australian and New Zealand context is proposed as a significant opportunity to meet an urgent need. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

39. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial

Author

Kuut, Tanja A, primary, Müller, Fabiola, additional, Csorba, Irene, additional, Braamse, Annemarie, additional, Aldenkamp, Arnoud, additional, Appelman, Brent, additional, Assmann-Schuilwerve, Eleonoor, additional, Geerlings, Suzanne E, additional, Gibney, Katherine B, additional, Kanaan, Richard A A, additional, Mooij-Kalverda, Kirsten, additional, Hartman, Tim C Olde, additional, Pauëlsen, Dominique, additional, Prins, Maria, additional, Slieker, Kitty, additional, van Vugt, Michele, additional, Keijmel, Stephan P, additional, Nieuwkerk, Pythia, additional, Rovers, Chantal P, additional, and Knoop, Hans, additional

Published
2023
Full Text
View/download PDF

42. Functional movement disorder gender, age and phenotype study

Author

Lidstone, Sarah C, Costa-Parke, Michael, Robinson, Emily J, Ercoli, Tommaso, Stone, Jon, Collaborators Omar Ahmad, Sepideh, Akbaripanahi, Albanese, Alberto, Selma, Aybek, José Fidel Baizabal- Carvallo, Beek, Peter J., Bhatia, Kailash P., Verónica, Cabreira, Carson, Alan J., Castagna, Anna, Dale, Russell C., Carlo, Dallocchio, Giovanni, Defazio, Bertrand, Degos, Benedetta, Demartini, Günther, Deuschl, Galina, Diukova, Duque, Kevin R., Edwards, Mark J., Epstein, Steven A., Espay, Alberto J., Factor, Stewart A., Beatrice, Garcin, Geroin, Christian, Muriel, Hagenaars, Mark, Hallett, Thomas, Hassa, Anhar, Hassan, Herbert, Lorena D., Holden, Samantha K., Joseph, Jankovic, Kanaan, Richard A., Lianne, Kempe, Maja, Kojovic, Katie, Kompoliti, Kostić, Vladimir S., Kevin, Kyle, Kathrin, Lafaver, Lang, Anthony E., Lindsey, Macgillivray, Davide, Martino, João, Massano, Maurer, Carine W., Laura, Mcwhirter, Raja, Mehanna, Francine, Mesrati, Morris, John C., Glenn, Nielsen, Anastasia, Obukhova, Sanjay, Pandey, Perez, David L., Igor, Petrović, Pullman, Seth L., Angelo, Quartarone, Karin, Roelofs, Anette, Schrag, Yury, Seliverstov, Tereza, Serranová, Ulf, Søgaard, Petr, Sojka, Maria, Stamelou, Stephen, Christopher D., Stins, John F., Tinazzi, Michele, Aleksandra, Tomić, Anabela, Valadas, Valerie, Voon, Waugh, Jeff L., and Allan, D. Wu.

Subjects
Movement Disorders, 230 Affective Neuroscience, systematic reviews, meta-analysis, Experimental Psychopathology and Treatment, Psychiatry and Mental health, Dystonia, Phenotype, Conversion Disorder, SDG 3 - Good Health and Well-being, functional neurological disorder, Tremor, Humans, Surgery, Female, Neurology (clinical)
Abstract

Contains fulltext : 289359.pdf (Publisher’s version ) (Closed access) Functional movement disorder (FMD) is a common manifestation of functional neurological disorder presenting with diverse phenotypes such as tremor, weakness and gait disorder. Our current understanding of the basic epidemiological features of this condition is unclear. We aimed to describe and examine the relationship between age at onset, phenotype and gender in FMD in a large meta-analysis of published and unpublished individual patient cases. An electronic search of PubMed was conducted for studies from 1968 to 2019 according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Individual patient data were collected through a research network. We described the distribution of age of onset and how this varied by gender and motor phenotype. A one-stage meta-analysis was performed using multilevel mixed-effects linear regression, including random intercepts for country and data source. A total of 4905 individual cases were analysed (72.6% woman). The mean age at onset was 39.6 years (SD 16.1). Women had a significantly earlier age of onset than men (39.1 years vs 41.0 years). Mixed FMD (23.1%), tremor (21.6%) and weakness (18.1%) were the most common phenotypes. Compared with tremor (40.7 years), the mean ages at onset of dystonia (34.5 years) and weakness (36.4 years) were significantly younger, while gait disorders (43.2 years) had a significantly later age at onset. The interaction between gender and phenotype was not significant. FMD peaks in midlife with varying effects of gender on age at onset and phenotype. The data gives some support to ‘lumping’ FMD as a unitary disorder but also highlights the value in ‘splitting’ into individual phenotypes where relevant.Data are available upon reasonable request. 8 p.

Published
2022

46. Main and moderated effects of multimorbidity and depressive symptoms on cognition

Author

de Araujo, Jacyra Azevedo Paiva, Xavier, Érika Fialho Morais, Rodrigues, Elisângela da Silva, Machado, Daiane Borges, Barreto, Marcos E., Kanaan, Richard A., Barreto, Mauricio L., and Castro-De-araujo, Luis Fernando Silva

Subjects
RA0421 Public health. Hygiene. Preventive Medicine
Abstract

OBJECTIVE: Multimorbidity, or the occurrence of two or more chronic conditions, is a global challenge, with implications for mortality, morbidity, disability, and life quality. Psychiatric disorders are common among the chronic diseases that affect patients with multimorbidity. It is still not well understood whether psychiatric symptoms, especially depressive symptoms, moderate the effect of multimorbidity on cognition. METHODS: We used a large (n=2,681) dataset to assess whether depressive symptomatology moderates the effect of multimorbidity on cognition using structural equation modelling. RESULTS: It was found that the more depressive symptoms and chronic conditions, the worse the cognitive performance, and the higher the educational level, the better the cognitive performance. We found a significant but weak (0.009; p = 0.04) moderating effect. CONCLUSION: We have provided the first estimate of the moderating effect of depression on the relation between multimorbidity and cognition, which was small. Although this moderation has been implied by many previous studies, it was never previously estimated.

Published
2022

47. Main and moderated effects of multimorbidity and depressive symptoms on cognition

Author

de Araujo,Jacyra Azevedo Paiva, Xavier,Érika Fialho Morais, Rodrigues,Elisângela da Silva, Machado,Daiane Borges, Barreto,Marcos E., Kanaan,Richard A., Barreto,Mauricio L., and Castro-de-Araujo,Luis Fernando Silva

Subjects
aging, Multimorbidity, epidemiology, structural equation modeling
Abstract

Objective: Multimorbidity, or the occurrence of two or more chronic conditions, is a global challenge, with implications for mortality, morbidity, disability, and life quality. Psychiatric disorders are common among the chronic diseases that affect patients with multimorbidity. It is still not well understood whether psychiatric symptoms, especially depressive symptoms, moderate the effect of multimorbidity on cognition. Methods: We used a large (n=2,681) dataset to assess whether depressive symptomatology moderates the effect of multimorbidity on cognition using structural equation modelling. Results: It was found that the more depressive symptoms and chronic conditions, the worse the cognitive performance, and the higher the educational level, the better the cognitive performance. We found a significant but weak (0.009; p = 0.04) moderating effect. Conclusion: We have provided the first estimate of the moderating effect of depression on the relation between multimorbidity and cognition, which was small. Although this moderation has been implied by many previous studies, it was never previously estimated.

Published
2022

49. Multimorbidity worsened anxiety and depression symptoms during the COVID-19 pandemic in Brazil

Author

Castro-de-Araujo, Luis Fernando Silva, primary, Rodrigues, Elisângela da Silva, additional, Machado, Daiane Borges, additional, Henriques, Claudio Maierovitch Pessanha, additional, Verotti, Mariana Pastorello, additional, Gonçalves, Alessandra Queiroga, additional, Duarte-Salles, Talita, additional, Kanaan, Richard A., additional, Barreto, Mauricio Lima, additional, Lewis, Glyn, additional, and Barbosa, Jakeline Ribeiro, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results